Alteration of miR-362-5p and miR-454-3p expression elicits diverse responses in breast cancer cell lines
- 2 November 2021
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (1) , 821-826
Abstract
Background The heterogeneity of breast tumors presents a challenge in disease management, necessitating an understanding of the molecular mechanisms driving breast tumorigenesis. Aberrant expression of microRNAs is known to promote tumor growth and progression. Our previous RNA-sequencing dataset revealed the upregulation of miR-362-5p and miR-454-3p in breast tumors. We investigated potential role of miR-362-5p and miR-454-3p in breast cancer using MDAMB231 and MCF7 cell lines. Methods and results The expression of miR-362-5p and miR-454-3p were altered in MCF7 and MDAMB231 using mimics and inhibitors. The effect on cell viability, cell cycle progression and migration was assessed using Alamar blue assay, flow cytometry and wound healing assay. Further, the expression of potential target genes were measured using real-time PCR. Our results indicated that an increased expression of miR-362-5p promoted cell growth and survival in MCF7, but decreased cell migration. In contrast, miR-362-5p overexpression reduced cancer cell growth, survival and migration in MDAMB231. Overexpression of miR-454-3p was oncogenic in both cell lines but suppressed migration in the aggressive cell line MDAMB231. Conclusion Two microRNAs, miR-362-5p and miR-454-3p, were evaluated for functional activity in breast cancer cell lines and they showed increased proliferative signals and tumorigenic properties.Keywords
Funding Information
- Department of Biotechnology , Ministry of Science and Technology (BT/PR8152/AGR/36/739/2013)
This publication has 15 references indexed in Scilit:
- MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer MetastasisTheranostics, 2019
- sRNAPrimerDB: comprehensive primer design and search web service for small non-coding RNAsBioinformatics, 2018
- MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancerJournal of Biological Research-Thessaloniki, 2017
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival AnalysesNeoplasia, 2017
- Molecular characterization of breast cancer cell lines through multiple omic approachesBreast Cancer Research, 2017
- Molecular heterogeneity in breast cancer: State of the science and implications for patient careSeminars in Cell & Developmental Biology, 2017
- High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancerOncotarget, 2016
- The role of MicroRNAs in human cancerSignal Transduction and Targeted Therapy, 2016
- MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinomaCancer Letters, 2015
- Coregulation of Estrogen Receptor by ERBB4/HER4 Establishes a Growth-Promoting Autocrine Signal in Breast Tumor CellsCancer Research, 2006